Evid Invest
Holders — by stockHoldings — by fund

Exome Asset Management LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0002011932

$153.0M

disclosed book value

55

positions

7.9%

largest position share

Positions, as of 2026-09-30

top 55 of 55 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1GHGUARDANT HEALTH INC67,500$12.0M7.9%
2TGTXTG THERAPEUTICS INC187,671$10.5M6.8%
3ABVXABIVAX SA90,919$9.0M5.9%
4PRAXPRAXIS PRECISION MEDICINES I29,681$8.6M5.6%
5COGTCOGENT BIOSCIENCES INC210,523$6.7M4.4%
6LLYELI LILLY & CO5,492$6.4M4.2%
7NTRANATERA INC13,800$5.7M3.7%
8VERAVERA THERAPEUTICS INC159,556$5.2M3.4%
9VKTXVIKING THERAPEUTICS INC147,497$4.8M3.1%
10IONSIONIS PHARMACEUTICALS INC107,034$4.8M3.1%
11ELVNENLIVEN THERAPEUTICS INC100,203$4.6M3%
12CAICARIS LIFE SCIENCES INC146,093$4.5M2.9%
13NKTRNEKTAR THERAPEUTICS73,708$4.5M2.9%
14CYTKCYTOKINETICS INC60,056$4.0M2.6%
15VSTMVERASTEM INC429,041$3.5M2.3%
16MAZEMAZE THERAPEUTICS INC114,692$3.1M2%
17RYTMRHYTHM PHARMACEUTICALS INC32,209$3.1M2%
18TXG10X GENOMICS INC30,074$2.7M1.8%
19ALKSALKERMES PLC61,336$2.5M1.6%
20UTHRUNITED THERAPEUTICS CORP DEL4,109$2.2M1.5%
21BSXBOSTON SCIENTIFIC CORP48,347$2.1M1.4%
22ARWRARROWHEAD PHARMACEUTICALS IN32,214$2.1M1.4%
23UNHUNITEDHEALTH GROUP INC5,697$2.1M1.4%
24OCULOCULAR THERAPEUTIX INC272,046$2.1M1.4%
25ALMSALUMIS INC282,253$2.1M1.4%
26PENPENUMBRA INC6,300$2.0M1.3%
27ISRGINTUITIVE SURGICAL INC4,908$2.0M1.3%
28MLTXMOONLAKE IMMUNOTHERAPEUTICS166,493$1.9M1.3%
29CMPSCOMPASS PATHWAYS PLC153,087$1.9M1.2%
30CLDXCELLDEX THERAPEUTICS INC NEW56,269$1.8M1.2%
31MRKMERCK & CO INC12,358$1.8M1.2%
32LQDALIQUIDIA CORPORATION59,155$1.8M1.2%
33GKOSGLAUKOS CORP10,862$1.8M1.2%
34GLUEMONTE ROSA THERAPEUTICS INC137,015$1.6M1.1%
35BBIOBRIDGEBIO PHARMA INC21,209$1.4M0.9%
36CLPTCLEARPOINT NEURO INC110,174$1.3M0.9%
37CRBPCORBUS PHARMACEUTICALS HLDGS190,714$1.3M0.8%
38CTMXCYTOMX THERAPEUTICS INC.460,067$1.3M0.8%
39PVLAPALVELLA THERAPEUTICS INC NE7,809$1.1M0.7%
40ASNDASCENDIS PHARMA A/S4,414$1.0M0.7%
41RAPPRAPPORT THERAPEUTICS INC29,381$987,2020.6%
42BLLNBILLIONTOONE INC8,983$956,1510.6%
43ZBIOZENAS BIOPHARMA INC34,341$926,1770.6%
44REPLREPLIMUNE GROUP INC68,488$906,7810.6%
45EQEQUILLIUM INC552,956$898,5540.6%
46ESTAESTABLISHMENT LABS HLDGS INC13,100$840,6270.5%
47CLYMCLIMB BIO INC71,215$816,8360.5%
48NBPNOVABRIDGE BIOSCIENCES576,960$787,5500.5%
49DRUGBRIGHT MINDS BIOSCIENCES INC14,715$733,1010.5%
50CMPXCOMPASS THERAPEUTICS INC511,084$531,5270.3%
51QTTBQ32 BIO INC62,589$517,6110.3%
52CAPRCAPRICOR THERAPEUTICS INC51,531$487,9990.3%
53QUREUNIQURE NV18,300$442,1280.3%
54ABUSARBUTUS BIOPHARMA CORP50,166$239,7930.2%
55ADAGADAGENE INC52,543$168,1380.1%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.